EPICA-DIPG

EPICA-DIPG is a European research project evaluating whether a new immunotherapy approach for diffuse intrinsic pontine glioma (DIPG) can be delivered safely, monitored effectively, and implemented across centres.

It brings together treatment, monitoring and delivery into a single early-phase clinical trial designed to generate the evidence needed for future studies.

EPICA-DIPG has received funding from the European Union’s Horizon Europe Research and Innovation programme under grant agreement No 101286703. 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.